Unknown

Dataset Information

0

Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape-Driven Relapse in Multiple Myeloma.


ABSTRACT: CAR T-cell therapy for multiple myeloma (MM) targeting B-cell maturation antigen (TNFRSF17; BCMA) induces high overall response rates; however, relapse occurs commonly. Implicated in relapse is a reservoir of MM if cells lacking sufficient BCMA surface expression (antigen escape). We demonstrate that simultaneous targeting of an additional antigen-here, G protein-coupled receptor class-C group-5 member-D (GPRC5D)-can prevent BCMA escape-mediated relapse in a model of MM. To identify an optimal approach, we compare subtherapeutic doses of different forms of dual-targeted cellular therapy. These include (1) parallel-produced and pooled mono-targeted CAR T-cells, (2) bicistronic constructs expressing distinct CARs from a single vector, and (3) a dual-scFv "single-stalk" CAR design. When targeting BCMA-negative disease, bicistronic and pooled approaches had the highest efficacy, whereas for dual-antigen-expressing disease, the bicistronic approach was more efficacious than the pooled approach. Mechanistically, expressing two CARs on a single cell enhanced the strength of CAR T-cell/target cell interactions.

SUBMITTER: de Larrea CF 

PROVIDER: S-EPMC7575057 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC10504087 | biostudies-literature
| S-EPMC10309537 | biostudies-literature
| S-EPMC11319832 | biostudies-literature
| S-EPMC10700430 | biostudies-literature
2023-06-29 | GSE226336 | GEO
2023-06-29 | GSE226335 | GEO
2023-06-29 | GSE226327 | GEO
| S-EPMC10798961 | biostudies-literature